Sarepta Therapeutics (SRPT) Says Exondys-51 List Price to be $300K/Year

September 19, 2016 4:13 PM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Sarepta Therapeutics (NASDAQ: SRPT) Says Exondys-51 List Price to be $300K/Year



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Hot Corp. News, Momentum Movers

Add Your Comment